(Q37362687)

19 August 2017

1 reference

title

Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world (English)

1 reference

19 August 2017

0 references

P Margozzini

1

1 reference

19 August 2017

A Rigotti

2

1 reference

19 August 2017

C Ferreccio

3

1 reference

19 August 2017

N Quezada

4

1 reference

19 August 2017

M Garrido

5

1 reference

19 August 2017

G Valdés

6

1 reference

19 August 2017

publication date

1 October 2007

1 reference

Therapeutic advances in cardiovascular disease

19 August 2017

published in

1 reference

19 August 2017

volume

1

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

83-90

1 reference

High prevalence of metabolic syndrome in Mexico

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Insulin causes endothelial dysfunction in humans: sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Is visceral obesity the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The hypertension-lipid connection: insights into the relation between angiotensin II and cholesterol in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Hypertension genes are genetic markers for insulin sensitivity and resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The evolving role of inflammation in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Metabolic syndrome: historical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Role of insulin resistance in human disease (syndrome X): an expanded definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Pathophysiology of insulin resistance in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The metabolic syndrome: requiescat in pace

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The metabolic syndrome, inflammation and cardiovascular disease in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

The metabolic syndrome: a glance at its history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Insulin and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Pathophysiology and treatment of obesity hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

Metabolic Syndrome: Older than Usually Assumed, But Still Too Young to Die

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082716

21 January 2018

Identifiers

DOI

10.1177/1753944707082716

1 reference

19 August 2017

1 reference